Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Famous mineralogists visit UFS Geology
2017-04-25

Description: Famous mineralogists visits UFS Geology Tags: Famous mineralogists visits UFS Geology

From the left: Prof Marian Tredoux, Associate
Professor at the UFS Department of Geology;
Prof Giorgio Garuti; from the University of Leoben,
Dr Federica Zaccarini, also from the
University of Leoben and Dr Freddie Roelofse,
Head of the Department of Geology at the UFS.
Photo: Rulanzen Martin


Years of academic friendship and collaboration is what makes Prof Giorgio Garuti and Dr Federica Zaccarini return to the University of the Free State (UFS) every so often.

The world-renowned academic duo from the University of Leoben in Austria were guest lecturers at the UFS Department of Geology. “We are here because we have known Professor Marian Tredoux and the Geology Department, for a long time. We are really happy to be here, and to be given the opportunity to present talks,” said Dr Zaccarini. The two are experts in platinum-group element mineralogy and each has given their surname to minerals namely, the Garutiite and Zaccariniite minerals.

Visit great advantage for research

They are acclaimed experts on very small minerals (smaller than a hundredth of a millimetre) with emphasis on platinum group elements in chrome-rich rocks. “Their visit is a great advantage for us. We also conduct research on these minerals and can learn from them,” said Prof Marian Tredoux, affiliated researcher at the Department of Geology.

Dr Zaccarini gave a lecture on Chromitites, and associated platinum-group elements, in ophiolites on Wednesday 5 April 2017 and Dr Garuti presented a lecture on Uralian-Alaskan complexes: a puzzling source of platinum, on Thursday 6 April 2017. During the talks they examined the association of the platinum-group minerals with chromite, rather than sulphide, and how this association can lead to the formation of unusual platinum-group element ores.

Collaboration on various academic papers

They and Prof Tredoux have collaborated on various research articles over the past four years, which have been published in various important international scientific journals. “These journals play an important role in calculating the H-scale which measures how important a researcher’s work is on an international scale,” said Prof Tredoux.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept